Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
82 Cards in this Set
- Front
- Back
Histamine is formed from which amino acid?
|
from the decarboxylation of L-histidine
|
|
Where is histamine sequestered?
|
mainly in the mast cells and basophils, the brain, and the enterochromaffin-like (ECL) cells of the fundus of the stomach
|
|
True or False
Histamine is only active in the bound form. |
FALSE
Histamine is biologically INACTIVE in the bound form. |
|
List the histamine receptors and where they are located.
|
H1 - sm.m., endothelium, brain
H2 - gastric mucosa, cardiac m., mast cells, brain H3 - presynaptic: brain, myenteric plexus H4 - eosinophils, neutrophils, CD4 T-cells |
|
respiratory effect of histamine.
|
bronchoconstriction due to H1 stimulation
|
|
CV effect of histamine
|
increased contractility
increased HR due to H2 stim. and reflex tachycardia from H1 stim resulting in vasodilator effects on arterioles |
|
GI effects of histamine
|
smooth muscle contraction due to H1 stim
increased secretions due to H2 stim |
|
What is the "triple response" of a histamine reaction.
|
sm.m in microcirc --> dilation
endothelial cells of cap. and veins --> extravasation of fluid sensory nerve endings --> pain stim. and flare |
|
char. of 1st generation antihistamines
|
strong sedative effect related to CNS distribution
duration of action varies due to CNS distribution |
|
char. of 2nd generation antihistamines
|
metabolized by CYP3A4 system
duration of action varies due to metabolization by CYP3A4 |
|
Where are prostaglandins produced?
|
in virtually all tissues and in minute quantities
|
|
What is the precursor to prostaglandin synthesis?
|
arachidonic acid
(20 carbon fatty acid) |
|
Why are prostaglandins referred to as eicosanoids?
|
'eicosa' refers to the 20 carbon atoms
|
|
List the groups of eicosanoids with ring structures.
|
prostaglandins
thromboxanes prostaglandins these are all synthesized by the cyclooxygenase pathway |
|
What is COX-1 responsible for synthesizing?
|
the physiologic production of prostaglandins, ie our everyday prostanoids such as those that regulate normal cell function (gastric cytoprotection, vascular homeostasis, platelet aggregation)
|
|
What is COX-2 responsible for synthesizing?
|
prostaglandins that occur in sites of disease and inflammation
|
|
Which has a larger substrate binding site, cox-1 or cox-2?
|
cox-2
the larger binding site permitted the development of cox-2 selective inhibitors |
|
Which is inhibited by glucocorticoids, cox-1 or cox-2?
|
cox-2
|
|
What is the lipoxygenase pathway?
|
the action of lipoxygenase on arachidonic acid to form 5-HPETE, 12-HPETE and 15-HPETE, which are unstable and converted into the hydroxylated derivatives known as the HETES
|
|
What are the unstable prostaglandins in prostaglandin synthesis and into what are they transformed?
|
PGG2 & PGH2
transformed into PGE2, PGI2, PGD2, PGF2 AND TXA2 |
|
Which prostaglandin is more predominant in platelets?
|
TXA2
|
|
Which prostaglandin is more predominant in vascular endothelium?
|
PGI2
|
|
What is the significance of PGE3 in fish oils?
|
if ingested in significant amounts, it diminished the proinflammatory production of PGE2 and the generation of TXA2 resulting in an anti-inflammatory and CV benefit
|
|
What is the half-life of prostaglandins?
|
one minute
except for PGI2 (5 minutes) and TXA2 (30 seconds) |
|
What kind of receptors are associated with prostaglandins?
|
G protein coupled receptors
|
|
List the prostaglandin receptors.
|
DP, FP, IP, EP and TP
they correlate with the prostaglandin it associates with. i.e. DP to PGD2; FP to PGF2 |
|
Actions of PGD2.
|
vasodilation
inhibition of platelet aggregation relaxation of GI and uterine muscle bronchoconstrictor |
|
Actions of PGF2.
|
myometrial contraction
some bronchoconstriction |
|
Actions of PGI2
|
vasodilation
inhibition of platelet aggregation renin release & natriuresis |
|
Actions of PGE2
|
on EP1 receptors - contraction of bronchial & GI smooth muscle
on EP2 receptors - bronchodilation, vasodilation, increased intestinal fluid secretion, relaxes GI smooth muscle on EP3 receptors - GI smooth muscle contraction, inhibits gastric acid secretion, increased gastric mucous secretion, inhibits ANS neurotransmitter release |
|
Actions of TXA2
|
vasoconstriction
platelet aggregation bronchoconstriction |
|
Which prostaglandins are released in an acute inflammatory response?
|
PGE2 (predominates) & PGI2 are released by local tissues/blood vessels while mast cells release PGD2.
|
|
What do mast cells release?
|
PGD2
|
|
True or False
Prostaglandins directly increase the permeability of postcapillary venules resulting in the redness and swelling associated with an acute inflammatory response. |
FALSE
They potentiate the effects of histamine and bradykinin. |
|
True or False
The release of prostaglandins during an acute inflammatory response results in pain as a result of the redness and swelling. |
FALSE
They potentiate the effect of bradykinin by sensitizing the afferent C fibers to the effects of the noxious stimuli. |
|
What drug is used to maintain the patency of the ductus arteriosus until surgical correction.
|
alprostadil (via PGE1)
|
|
Which prostaglandin agonist is used to treat open-angle glaucoma?
|
latanoprost
|
|
Which enzyme is responsible for producing leukotrienes?
|
5-lipoxygenase
|
|
char. of LTB4
|
chemotactic agent for neutrophils and macrophages
|
|
The anti-inflammatory effects of NSAIDS is related to the inhibition of (cox-1/cox-2) _______.
|
cox-2
|
|
The unwanted effects of NSAIDS, especially GI, are related to the inhibition of cox-1/cox-2) _______.
|
cox-1
|
|
True or False
NSAIDS can effect normal body temperature. |
FALSE
The antipyretic effects of NSAIDS are a result of inhibition of prostaglandin production in the hypothalamus. |
|
How does the analgesic effect of NSAIDS work?
|
1. they decrease PG production that sensitizes nociceptors to inflammatory mediators like bradykinin
2. decrease PG production in the spinal cord, decreasing transmission from afferent pain fibers. |
|
What components of inflammation do NSAIDS reduce?
|
vasodilation
edema pain |
|
3 main desired effects of NSAIDS
|
anti-inflammatory
analgesic antipyretic |
|
cox-1 or cox-2
NSAIDS inhibiting this pathway result in a rapid and reversible inhibition. |
COX-1
|
|
NSAIDS inhibiting this pathway result in an irreversible reaction.
|
COX-2
|
|
List some unwanted side effects of NSAIDS use.
|
GI - dyspepsia, N/V, ulcers
skin rashes reversible renal insufficiency liver disorders bone marrow suppression analgesic associated nephropathy |
|
ASA is more selective for cox-1 or cox-2?
|
cox-1
|
|
characteristics of ASA.
|
cox-1 selective
inhibits thromboxane production in platelets irreversible inhibition of cox-1 changes ratio of prostacyclin to thromboxane |
|
What percent of platelets is renewed every 24 hrs? Why is this significant for ASA dosing?
|
1/7 or 14% of platelets are renewed every 24hrs.
This is significant in ASA dosing due to the irreversible inhibition of TXA2 prod in platelets requiring DAILY dosing for effectiveness rather that QOD dosing. |
|
True or False
NSAIDS can be taken as a preventative measure to reduce CV risk. |
FALSE
ASA has been shown to reduce CV risk by 30% whereas NSAIDS show no reduction in CV risk. |
|
If we have to admin both ASA and NSAIDS, which do we give first and why?
|
ASA first, then NSAIDS at least 30 min. later b/c NSAIDS block the cox-1 pathway where ASA works.
In the event the ASA is enteric coated, this does not apply. |
|
What are the 3 main risks with taking NSAIDS?
|
CV - increase risk of bleeding due to inhibition of platelet aggregation
GI - ulcers, bleeding obstructuve strictures renal - sodium and fluid retention, hyperkalemia, ARF, HTN |
|
When do we use a cox-2 inhibitor?
|
pts at high risk for GI bleed
use lowest effective dose (200mg for OA; 200-400mg for RA; 400mg for pain) avoid in pts with CV disease |
|
What are the 2 main prostaglandins synthesized in the kidney?
|
PGE2
PGI2 |
|
How do NSAIDS adversely effect the kidney?
|
via the cox-2 pathway, inhibits the beneficial effects of PGE2 and PGI2 in the kidney
inhibiting PGE2 results in sodium retention, fluid retention, HTN, vasoconstriction inhibiting PGI2 results in hyperkalemia and ARF |
|
Which of the following is/are prodrug(s)?
a. diclofenac b. sulindac c. naproxen d. ibuprofen |
b. sulindac
its metabolized in the liver to its active metabolite |
|
True or False
It's acceptable to substitute a different NSAID for one which a pt has had a reaction. |
FALSE
There is cross reactivity between ASA and NSAIDS due to a redirection of arachidonic acid metabolism resulting in increased leukotrienes. |
|
The majority of NSAIDS are weak acids or weak bases?
|
weak acids
|
|
What does it mean when the therapeutic index of a drug is high?
|
The higher the TI, the more safe the drug.
|
|
Which NSAID is labeled renal-sparing?
|
sulindac
|
|
What is the significance of ketorolac?
|
It's the first injectable NSAID for analgesia. Enhanced efficacy due to its injectability.
If used with an opioid, it decreases the required amt of opioid needed for pain relief. |
|
Which NSAID requires taking it on an empty stomach?
|
fenoprofen
due to absorption problems with the drug |
|
What should we be aware of when admin oxicams?
|
high incidence of GI toxicity and phototoxic cutaneous eruptions
no longe used in Europe; FDA still approves use for menstrual cramps and short term pain relief in US |
|
Name the pyrazoles. What is the problem with pyrazole administration?
|
phenylbutazone
oxyphenbutazone SE of aplastic anemia with a 50% mortality rate administration can not exceed 1 week. |
|
Indications for celebrex admin.
|
osteoarthritis
RA FAP (familial adenomatous polyps) |
|
Why is celebrex effective in treating FAP?
|
FAP (familial adenomatous polyps) has been shown to express Cox-2, which celebrex blocks as a cox-2 inhibitor
|
|
What is salicylism?
|
high dose ASA admin resulting in tinnitus, decreased hearing and vertigo
|
|
List salicylates. How do the others differ from ASA?
|
magnesium choline salicylate
sodium salicylate salicylsalicylate they are less efficacious slower onset no ASA hypersensitivity no drug interactions less GI side effects |
|
What effects does acetaminophen have?
|
antipyretic
analgesic little anti-inflammatory effect |
|
What is the active metabolite of acetaminophen and what is its significance?
|
N-acetyl-benzoiminoquinone
it is hepatic and renal toxic treated with N-acetylcysteine |
|
characteristics of acetaminophen
|
very little protein bound
very little drug interactions mild adverse effects (except with OD) |
|
What is gout?
|
deposition of monosodium urate crystals in joints and soft tissue
|
|
What is 'usually' the first body part affected by gout?
|
the big toe
|
|
what is the enzyme responsible for uric acid production?
|
xanthine oxidase
|
|
Uric acid is made from what compound(s)?
|
purines, which is converted to hypoxanthine
|
|
normal plasma urate level
|
4-6 mg/dl
|
|
types of gout patients
|
overproducers and underexcretors
90% of pts are underexcretors |
|
What drug(s) are used for acute gouty attacks?
|
colchicine - it reduces leukocyte migration into joints
NSAIDS |
|
What drug(s) are used for chronic gouty attacks?
|
probenecid
sulfinpyrazone |
|
What drug(s) are used to prevent gouty attacks? How do they work?
|
allopurinol - competitive inhibition of xanthine oxidase
|